NVAX 8-K: SEC filing
Novavax, Inc.
Filed with the SEC on · accession 0001000694-26-000021
NVAX filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Novavax, Inc. filed a Form 8-K on November 5, 2026, announcing its financial results for the third quarter ended September 30, 2026, via an attached press release.
Key details
✦ Ask GOAX AI about this filing — what it means for NVAX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NVAX?
Click hereFrequently asked questions
What did NVAX file with the SEC on Nov 5, 2026?
NVAX filed a 8-K (SEC filing). Novavax, Inc. filed a Form 8-K on November 5, 2026, announcing its financial results for the third quarter ended September 30, 2026, via an attached press release.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other NVAX SEC filings
Get alerts when NVAX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days